iPhone | iPad
Android
Huawei
The temporary ban will stay 'until the identified threats are eliminated and a new theological conclusion is reached', says Dagestan Muftiate
KT APPDOWNLOAD
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Around 11 per cent of Indian adults will be obese by 2035, according to the World Obesity Federation Atlas
A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly at Rock Canyon Pharmacy in Provo, Utah, US on March 29, 2023. — Reuters
An Indian government-approved expert panel has advised the country's drug regulator to approve the import and sale of US drugmaker Eli Lilly's Mounjaro, a blockbuster diabetes drug and a wildly popular obesity treatment, a document on a government website showed on Monday.
Lilly's Mounjaro, chemically known as tirzepatide, and Zepbound and Danish rival Novo Nordisk's Wegovy and Ozempic belong to a class of therapies known as GLP-1 receptor agonists, developed to control blood sugar in patients with type 2 diabetes.
They also slow digestion, helping patients feel full longer, making them a wildly popular choice for weight loss.
"After detailed deliberation, the committee recommended for grant of permission for import and marketing" of certain doses of tirzepatide "for chronic weight management subject to the condition that firm should conduct Phase 4 clinical trial (post-marketing surveillance)," the Subject Expert Committee said in a notification dated June 19.
The committee advises India's drug regulator on approvals of drugs and trials.
"A recommendation from the subject expert committee is like the penultimate step of the approval," said Sheetal Sapale, vice-president of research firm Pharmarack.
Lilly did not immediately respond to a Reuters request for comment. CEO David Ricks had told Reuters a few months back that the company expected to launch Mounjaro in India as early as next year.
India has the world's second-highest number of people with type 2 diabetes and high obesity rates. Around 11 per cent of Indian adults will be obese by 2035, per the World Obesity Federation Atlas. The global weight-loss drugs market is estimated to reach at least $100 billion by the decade's end.
Lilly should also submit the required manufacturing and controls data, the expert panel added.
The notification was first reported by a local medical journal, The Indian Practitioner.
More news from World
Orban's visit to Ukraine comes the day after Hungary took over the EU's rotating presidency for the next six months
Stiell hails from the island of Carriacou which took a direct hit early Monday as Beryl barrelled through, dumping heavy rain and unleashing devastating winds
After four years of delays, the ESA's most powerful rocket yet is due to blast off from Europe's spaceport in Kourou on July 9
Aghamiri is one of Iran's dozen or so remaining masters of the ancient art of Tazhib, which was inscribed last year on Unesco's list of intangible heritage
Some 180-plus candidates have confirmed they will not stand in Sunday's second-round for France's 577-seat national parliament, according to local media estimates
A look at what Britons feel about the party they support and their leaders days before the country goes to the polls
The leader started the penultimate day of campaigning before Thursday's vote in a vast Ocado warehouse in Luton, watching robots pick items for delivery